Literature DB >> 20233530

Effects of metabolic syndrome on early mortality and morbidity in coronary artery bypass graft patients.

A Ozyazicioglu1, S Yalcinkaya, A H Vural, G Yumun, O Bozkurt.   

Abstract

Metabolic syndrome is a well-known cardiovascular risk factor closely related to increased insulin resistance. This study assessed the effects of metabolic syndrome on early post-operative mortality and morbidity in 100 coronary artery bypass graft (CABG) patients: 50 patients with and 50 without metabolic syndrome. A total of 17 patients were excluded from the analysis as they did not attend follow-up, leaving 51 males (61.4%) and 32 (38.6%) females of mean +/- SD age 60.02 +/- 9.76 years for analysis. Diabetes, hypertension and a high body mass index were significantly more common in patients with metabolic syndrome. A statistically significant relationship was found between metabolic syndrome and surgical wound infection. Non-significant positive correlations were found between metabolic syndrome and post-operative atrial fibrillation, surgical revision due to haemorrhage, ventricular tachycardia and ventricular fibrillation, and prolonged intubation. In conclusion, metabolic syndrome did not affect mortality, but did increase the risk of post-operative surgical wound infection.

Entities:  

Mesh:

Year:  2010        PMID: 20233530     DOI: 10.1177/147323001003800123

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  7 in total

1.  Metabolic syndrome and outcome after breast reconstruction.

Authors:  Areerat Ounhasuttiyanon; Visnu Lohsiriwat
Journal:  Gland Surg       Date:  2014-02

2.  Impact of metabolic syndrome on mortality and morbidity after coronary artery bypass grafting surgery.

Authors:  Maryam Ardeshiri; Zahra Faritus; Zahra Ojaghi-Haghighi; Hooman Bakhshandeh; Faranak Kargar; Rokhsareh Aghili
Journal:  Res Cardiovasc Med       Date:  2014-08-05

3.  The effects of the metabolic syndrome on coronary artery bypass grafting surgery.

Authors:  Sevil Özkan; Fatih Özdemir; Oğuz Uğur; Refik Demirtunç; Ahmet Yavuz Balci; Mehmet Kizilay; Ünsal Vural; Mehmet Kaplan; Ibrahim Yekeler
Journal:  Cardiovasc J Afr       Date:  2016-07-13       Impact factor: 1.167

4.  Does metabolic syndrome predict surgical complications? A protocol for a systematic review and meta-analysis.

Authors:  Philip Norris; Nicholas Ralph; Clint Moloney
Journal:  Syst Rev       Date:  2017-06-17

5.  Metabolic syndrome increases operative mortality in patients with impaired left ventricular systolic function who undergo coronary artery bypass grafting: a retrospective observational study.

Authors:  Shuangkun Chen; Jiahui Li; Qianzhen Li; Zhihuang Qiu; Xijie Wu; Liangwan Chen
Journal:  BMC Cardiovasc Disord       Date:  2019-01-23       Impact factor: 2.298

Review 6.  Patients with metabolic syndrome have a greater rate of complications after arthroplasty: A systematic review and meta-analysis.

Authors:  Cui Guofeng; Yue Chen; Wei Rong; Liu Ruiyu; Wang Kunzheng
Journal:  Bone Joint Res       Date:  2020-05-16       Impact factor: 5.853

7.  Impact of Early Intravenous Haemostatic Drugs on Brain Haemorrhage Patients and Their Image Segmentation Based on RGB-D Images.

Authors:  Zhenzhen Wang; Yating Mou; Hao Li; Rui Yang; Yanxun Jia
Journal:  J Healthc Eng       Date:  2022-01-07       Impact factor: 2.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.